COMPANY
ABBVIE CORPORATION
ABBVIE CORPORATION: marketing authorisation holder for Leuprolide, Linaclotide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Leuprolide | LUPRON (DIN 00727695), Cancelled Post Market Regulator Health Canada |
|---|---|
| Leuprolide | LUPRON DEPOT (DIN 00836273), Marketed Regulator Health Canada |
| Leuprolide | LUPRON DEPOT (DIN 00884502), Marketed Regulator Health Canada |
| Leuprolide | LUPRON DEPOT (DIN 02148722), Cancelled Pre Market Regulator Health Canada |
| Leuprolide | LUPRON DEPOT (DIN 02148730), Cancelled Pre Market Regulator Health Canada |
| Leuprolide | LUPRON DEPOT (DIN 02230248), Marketed Regulator Health Canada |
| Leuprolide | LUPRON DEPOT (DIN 02239833), Marketed Regulator Health Canada |
| Leuprolide | LUPRON DEPOT (DIN 02239834), Marketed Regulator Health Canada |
| Leuprolide | LUPRON DEPOT (DIN 02562855), Marketed Regulator Health Canada |
| Linaclotide | CONSTELLA (DIN 02417162), Marketed Regulator Health Canada |
| Linaclotide | CONSTELLA (DIN 02417170), Marketed Regulator Health Canada |
| Linaclotide | CONSTELLA (DIN 02469510), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.